PB Fintech Cofounders Sell Shares Worth INR 920 Cr in Major Block Deal
Yashish Dahiya and Alok Bansal Book Profits Amid Strong FY25 Results
PB Fintech cofounders Yashish Dahiya and Alok Bansal executed large bulk and block deals on June 26, offloading a combined 1.1% of the company’s total equity and raising INR 619.6 Cr (Dahiya) and INR 300.6 Cr (Bansal), totaling INR 920 Cr.
- Dahiya sold 25 lakh shares and then another 9 lakh shares at INR 1,821.50 per share.
- Bansal sold 16.5 lakh shares at the same price.
- Buyers: Goldman Sachs, Morgan Stanley, Societe General, ICICI Prudential Life Insurance, Tata Mutual Fund, Citigroup, and others.
Transaction Impact and Lock-in
- The shares were sold at a 1% discount to the previous close (INR 1,839.75).
- The deal included a 90-day lock-in for the sellers, preventing further sales for three months.
- The block deal contributed to a 2% decline in PB Fintech’s share price during the session.
Financial Performance: Record Profit Growth
- FY25 net profit: INR 353.2 Cr (up 448% YoY from INR 64 Cr)
- Revenue: INR 4,977.2 Cr (up 45% YoY from INR 3,437.7 Cr in FY24)
- PolicyBazaar contributed INR 1,322.4 Cr (up 45% YoY), while other business lines, including PaisaBazaar, PB Pay, and DocPrime, added INR 185.5 Cr (up 6% YoY).
Recent Stock Trends and Market Context
- PB Fintech shares are down over 13.65% YTD despite strong earnings.
- The company has faced scrutiny for revenue recognition practices and transparency (Trudence Capital report).
- Recent strategic moves:
- INR 20 Cr investment in PB Pay (RBI approval for payment aggregator)
- New UAE subsidiary for Paisabazaar
- INR 539.4 Cr invested in PB Healthcare (now holding 40.32% stake); PB Healthcare recently raised $218 Mn in seed funding.
Bulk Deal Wave Across Tech Sector
- PB Fintech’s block deal is part of a flurry of large bulk transactions involving Indian new-age tech companies in 2025.
- Recent major deals include BNP Paribas, Antfin (Paytm), and block deals in Mobikwik, Nykaa, and Eternal.
PB Fintech’s cofounder share sale signals ongoing investor churn and profit-booking, even as the company reports record earnings. Leading global and domestic funds continue to see value in the stock, stepping in as major buyers.
